Comparison between Aurobindo Pharma Buyback 2026 and EMA Partners India Buyback 2026.
Aurobindo Pharma Buyback 2026 is a Tender Offer buyback proposed to list at BSE, NSE while EMA Partners India Buyback 2026 is a Tender Offer proposed to list at NSE.
| Aurobindo Pharma Ltd | Ema Partners India Ltd. | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Logo | ![]() | ![]() | ||||||||||||||||||
| Type of Buyback | Tender Offer | Tender Offer | ||||||||||||||||||
| Listing At | BSE, NSE | NSE | ||||||||||||||||||
| Face Value | ₹10 per share | ₹5 per share | ||||||||||||||||||
| Buyback Price | ₹1475 per share | ₹100 per share | ||||||||||||||||||
| Issue Size | 54,23,728 shares | 7,25,000 shares | ||||||||||||||||||
| Issue Size (Amount) | ₹800.00 Crores | ₹7.25 Crores | ||||||||||||||||||
| Buyback Ratio |
Note:
|
Note:
| ||||||||||||||||||
| Registrar | Kfin Technologies Ltd. | Bigshare Services Pvt.Ltd. | ||||||||||||||||||
| Lead Managers | Axis Capital Ltd. | Indorient Financial Services Ltd. | ||||||||||||||||||
| Necessity of the buyback | The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
|
Aurobindo Pharma Buyback 2026 and EMA Partners India Buyback 2026 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Aurobindo Pharma Buyback 2026 Buyback record date is Apr 17, 2026. EMA Partners India Buyback 2026 Buyback record date is Apr 30, 2026.
| Aurobindo Pharma Ltd | Ema Partners India Ltd. | |
|---|---|---|
| Record Date | Apr 17, 2026 | Apr 30, 2026 |
| Offer Open Date | Apr 23, 2026 | May 07, 2026 |
| Offer Closure Date | Apr 29, 2026 | May 13, 2026 |
| Last date for receipt of tender forms | Apr 29, 2026 | May 13, 2026 |
| Finalisation of buyback | May 07, 2026 | May 19, 2026 |
| Last Date for settlment of bids | May 07, 2026 | May 22, 2026 |
| Last Date for extinguishment of shares | May 18, 2026 | Jun 03, 2026 |
Comparison of Aurobindo Pharma Buyback 2026 and EMA Partners India Buyback 2026 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.
| Aurobindo Pharma Ltd | Ema Partners India Ltd. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stock price at BSE | Stock price at BSE (in preceding 3 months)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stock price at NSE | Stock price at NSE (in preceding 3 months)
| Stock price at NSE (in preceding 3 months)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||